Edwards Lifesciences | EW - Pre Tax Profit

Stock Price
82.39
Daily Change
1.01 1.24%
Monthly
1.17%
Yearly
5.57%
Q2 Forecast
79.74

Edwards Lifesciences reported $348.4M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 169.23M 25.24M Dec/2025
ICU Medical USD -15.9M 86.2M Dec/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 113M 27.2M Mar/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Masimo USD 71.3M 3.6M Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD 4.68M 29.82M Dec/2025
Teleflex USD 218.94M 657.52M Dec/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025